{"id":2762,"date":"2017-09-12T09:17:44","date_gmt":"2017-09-12T13:17:44","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=2762"},"modified":"2017-09-12T09:17:44","modified_gmt":"2017-09-12T13:17:44","slug":"cempra-cempnas-and-ophthotech-ophtnas-trading-at-less-than-cash-value-2","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2017\/09\/12\/cempra-cempnas-and-ophthotech-ophtnas-trading-at-less-than-cash-value-2\/","title":{"rendered":"Cempra (CEMP:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Trading at Less than Cash Value<\/h4>\n

Today we are looking at companies trading at less than cash value<\/strong> meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.<\/p>\n

What this Means…<\/h5>\n

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P\/E greater than 0 and are worth exploring in more detail.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nClose Price<\/th>\nShares Outstanding<\/th>\nP\/E<\/th>\nP\/B<\/th>\nCash per Share<\/th>\nNet Cash per Share<\/th>\n<\/tr>\n
CXDC<\/td>\nChina XD Plastics Co Ltd<\/td>\n4.700000<\/td>\n49511541<\/td>\n3.2639<\/td>\n0.3926<\/td>\n5.65<\/td>\n-11.27<\/td>\n<\/tr>\n
CEMP<\/td>\nCempra Inc<\/td>\n3.150000<\/td>\n52509281<\/td>\nNone<\/td>\n1.0853<\/td>\n3.56<\/td>\n3.33<\/td>\n<\/tr>\n
OPHT<\/td>\nOphthotech Corp<\/td>\n2.620000<\/td>\n35942879<\/td>\nNone<\/td>\nNone<\/td>\n3.92<\/td>\n5.86<\/td>\n<\/tr>\n
MLNK<\/td>\nModusLink Global Solutions Inc<\/td>\n1.570000<\/td>\n55554589<\/td>\nNone<\/td>\n1.2654<\/td>\n2.02<\/td>\n0.96<\/td>\n<\/tr>\n
GURE<\/td>\nGulf Resources Inc<\/td>\n1.770000<\/td>\n46796848<\/td>\n2.1585<\/td>\n0.2176<\/td>\n3.77<\/td>\n3.72<\/td>\n<\/tr>\n
SRRA<\/td>\nSierra Oncology Inc<\/td>\n1.550000<\/td>\n52268443<\/td>\nNone<\/td>\n0.7214<\/td>\n2.23<\/td>\n0.46<\/td>\n<\/tr>\n
CXRX<\/td>\nConcordia International Corp<\/td>\n1.320000<\/td>\n51143978<\/td>\nNone<\/td>\nNone<\/td>\n5.90<\/td>\n-63.98<\/td>\n<\/tr>\n
INFI<\/td>\nInfinity Pharmaceuticals Inc<\/td>\n1.210000<\/td>\n50689512<\/td>\nNone<\/td>\n1.0413<\/td>\n1.31<\/td>\n1.10<\/td>\n<\/tr>\n
ECYT<\/td>\nEndocyte Inc<\/td>\n1.420000<\/td>\n42575444<\/td>\nNone<\/td>\n0.5214<\/td>\n1.53<\/td>\n0.84<\/td>\n<\/tr>\n
WLB<\/td>\nWestmoreland Coal Co<\/td>\n2.240000<\/td>\n18742143<\/td>\nNone<\/td>\nNone<\/td>\n3.07<\/td>\n-54.31<\/td>\n<\/tr>\n
APWC<\/td>\nAsia Pacific Wire & Cable Corp Ltd<\/td>\n2.850000<\/td>\n13819669<\/td>\n13.5714<\/td>\n0.2897<\/td>\n3.49<\/td>\n1.44<\/td>\n<\/tr>\n
EVK<\/td>\nEver-Glory International Group Inc<\/td>\n2.500000<\/td>\n14792836<\/td>\n4.8077<\/td>\n0.4435<\/td>\n2.56<\/td>\n0.00<\/td>\n<\/tr>\n
PRPH<\/td>\nProPhase Labs Inc<\/td>\n2.280000<\/td>\n16166796<\/td>\n2.6824<\/td>\n0.7906<\/td>\n2.31<\/td>\n2.31<\/td>\n<\/tr>\n
OREX<\/td>\nOrexigen Therapeutics Inc<\/td>\n2.300000<\/td>\n15430966<\/td>\nNone<\/td>\nNone<\/td>\n2.38<\/td>\n-8.74<\/td>\n<\/tr>\n
GIGM<\/td>\nGigaMedia Ltd<\/td>\n3.010000<\/td>\n11052235<\/td>\nNone<\/td>\n0.5528<\/td>\n6.01<\/td>\n5.77<\/td>\n<\/tr>\n
TNXP<\/td>\nTonix Pharmaceuticals Holding Corp<\/td>\n4.270100<\/td>\n7508661<\/td>\nNone<\/td>\n0.9439<\/td>\n4.58<\/td>\n0.24<\/td>\n<\/tr>\n
VLRX<\/td>\nValeritas Holdings Inc<\/td>\n3.250000<\/td>\n6842978<\/td>\n3.5532<\/td>\n1.1761<\/td>\n6.18<\/td>\n1.20<\/td>\n<\/tr>\n
ABAC<\/td>\nAoxin Tianli Group Inc<\/td>\n2.160000<\/td>\n7983745<\/td>\nNone<\/td>\n0.1998<\/td>\n7.25<\/td>\n6.99<\/td>\n<\/tr>\n
CBIO<\/td>\nCatalyst Biosciences Inc<\/td>\n3.530000<\/td>\n4310561<\/td>\nNone<\/td>\n0.5014<\/td>\n7.51<\/td>\n6.18<\/td>\n<\/tr>\n
TEAR<\/td>\nTearLab Corp<\/td>\n1.510000<\/td>\n5742453<\/td>\nNone<\/td>\nNone<\/td>\n1.78<\/td>\n-2.98<\/td>\n<\/tr>\n
GLBR<\/td>\nGlobal Brokerage Inc<\/td>\n1.250000<\/td>\n6143305<\/td>\n0.8636<\/td>\nNone<\/td>\n77.62<\/td>\n50.74<\/td>\n<\/tr>\n
KONE<\/td>\nKingtone Wirelessinfo Solution Holding Ltd<\/td>\n3.120100<\/td>\n1405000<\/td>\n15.6005<\/td>\n0.2390<\/td>\n4.00<\/td>\n10.61<\/td>\n<\/tr>\n
MDGS<\/td>\nMedigus Ltd<\/td>\n2.040000<\/td>\n1992571<\/td>\nNone<\/td>\n1.1112<\/td>\n4.23<\/td>\nNone<\/td>\n<\/tr>\n
ROSG<\/td>\nRosetta Genomics Ltd<\/td>\n1.430000<\/td>\n2639375<\/td>\nNone<\/td>\n0.8545<\/td>\n2.34<\/td>\n0.90<\/td>\n<\/tr>\n
KBSF<\/td>\nKBS Fashion Group Ltd<\/td>\n1.980000<\/td>\n1772016<\/td>\nNone<\/td>\n0.0426<\/td>\n13.49<\/td>\n12.01<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

CEMP:NAS Cempra<\/h6>\n

http:\/\/www.cempra.com<\/a>
\nCempra has 45 employees and is headquartered in United States.
\nCempra Inc is a biotechnology company which develops differentiated antibiotics for acute care and community settings. Its goal is to develop treatments for bacterial infectious diseases, mainly respiratory tract infections and staphylococcal infections.<\/p>\n

OPHT:NAS Ophthotech<\/h6>\n

http:\/\/www.ophthotechinc.com<\/a>
\nOphthotech has 156 employees and is headquartered in United States.
\nOphthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

5 Free Days <\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n